News

A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...

America's Hottest New Real Estate Isn't For Humans—It's For AI

In 2022, office construction was five times larger than data center investment. Fast-forward to today, and the gap is closing ...